Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Allogene Therapeutics Inc.
Today
Create an eToro account to buy ALLO stock on a secure, user-friendly, multi-asset trading platform.
Buy Allogene Therapeutics Inc.
Buy Allogene Therapeutics Inc.
Allogene Therapeutics Inc. ALLO
Buy ALLO

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.
Stocks-ALLO-Allogene Therapeutics Inc.

Allogene Therapeutics Inc. ALLO

$1.640.02(1.23%)(1D)

ALLO Stock Price Chart

‎-23.33‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Allogene Therapeutics Inc. share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Allogene Therapeutics Inc. share price today is 1.64, reflecting a ‎1.23‎% change over the last 24 hours and ‎-11.05‎% over the past week. The current market capitalization of ALLO is 343.86M with an average volume in the last three months of 2.74M. The stock has a P/E ratio of -1.05 and a dividend yield of 0%. With the stock’s beta sitting at 1.72
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$343.86M
Day’s Range
i
Shows the high and low prices of the day.
1.59 - 2.08
52W Range
i
Shows the high and low prices of the last year.
1.59 - 5.76
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
2.74M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-1.05
Revenue
i
The total income generated by this company’s goods and services last year.
$43000
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$1.64
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-1.56
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.72
What Is Allogene Therapeutics Inc.?
Allogene Therapeutics is a US-based, clinical-stage, biotechnology healthcare company focussed on developing cancer treatments. The firm’s research is based on the development of allogeneic chimeric antigen receptor T-cell therapies. Founded in 2017, Allogene Therapeutics is based in San Francisco, California and is working to provide therapeutic treatments to patients worldwide who are living with hematologic cancers and solid tumours.

Allogene trades on the NASDAQ GS with the ticker ALLO. The company launched its IPO in October 2018 with what was generally considered to be one of the biggest and most lucrative public offerings in over a decade, raising $324m and resulting in a market value of over $2bn. ALLO stock rose more than 30% on its first day of public trading.

The company’s successful IPO was no doubt fuelled by previous well-publicised successes. In April 2018, the firm acquired Pfizer’s allogeneic CAR T portfolio and closed its Series A round of venture capital financing, raising $300m from a premium investment consortium made up of some of the leading names in biotechnology, such as Gilead and Pfizer.

Are you considering investing in this instrument? Get news and updates on price changes by adding ATT stock to your eToro watchlist now.
Buy ALLO

How can I buy Allogene Therapeutics Inc. stocks?

To purchase Allogene Therapeutics Inc.:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Allogene Therapeutics Inc. (ALLO) page and place an order to buy Allogene Therapeutics Inc..
Buy ALLO
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Go to the Academy >
Graph
Buy Allogene Therapeutics Inc.
Invest in Allogene Therapeutics Inc.
Today
Create an eToro account to buy ALLO stock on a secure, user-friendly, multi-asset trading platform.
Buy ALLO

FAQ

The current price of ALLO is 1.64.
The average price target for Allogene Therapeutics Inc. is 1.64. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Allogene Therapeutics Inc. based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Allogene Therapeutics Inc. is 343.86M
Daily Movers
Explore the biggest stocks movers on the market.
Buy ALLO
Scroll to top